Q97761279

Summary

Q97761279 is a committee group motion^[1].

Key Facts

• Q97761279 authored Emma Henriksson^[2].
• Q97761279 authored Cecilia Widegren^[3].
• Q97761279 authored Anders W. Jonsson^[4].
• Q97761279 authored Barbro Westerholm^[5].
• Q97761279's instance of is recorded as committee group motion^[6].
• Q97761279's part of the series is recorded as motions of 2016-2017 legislative session of the Riksdag^[7].
• Q97761279's language of work or name is recorded as Swedish^[8].
• Q97761279 was published on +2017-04-12T00:00:00Z^[9].
• Q97761279's main subject is medication^[10].
• Q97761279's work available at URL is recorded as http://data.riksdagen.se/dokument/H4023706^[11].
• Q97761279's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H4023706^[12].
• Q97761279's applies to jurisdiction is recorded as Sweden^[13].
• Q97761279's legal citation of this text is recorded as Mot. 2016/17:3706^[14].
• Q97761279's title is recorded as med anledning av prop. 2016/17:145 Vissa frågor om läkemedelsregistret^[15].
• Q97761279's has immediate cause is recorded as Q98120787^[16].
• Q97761279's cites work is recorded as Q98120787^[17].
• Q97761279's cites work is recorded as Q98457488^[18].
• Q97761279's cites work is recorded as Q98530014^[19].
• Q97761279's maintained by WikiProject is recorded as Project Riksdagen's documents^[20].
• Q97761279's copyright status is recorded as public domain^[21].
• Q97761279's legislative committee is recorded as Committee on Health and Welfare^[22].

Body

Definition and Type

Q97761279's instance of is recorded as committee group motion^[6].